Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …

The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …

always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

Background There is a paucity of data on the burden of in-stent restenosis (ISR) in the
United States as well as on its presentation and appropriate treatment strategies. Objectives …

Background Patients at high risk for bleeding who undergo percutaneous coronary
intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet …

Background We hypothesized that in patients with stable coronary artery disease and
stenosis, percutaneous coronary intervention (PCI) performed on the basis of the fractional …

Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Background The preferred initial treatment for patients with stable coronary artery disease is
the best available medical therapy. We hypothesized that in patients with functionally …

Background: Previous meta-analyses have investigated the relative safety and efficacy
profiles of different types of drug-eluting stents (DES) and bare-metal stents (BMS); however …

Since the first coronary angioplasty on Sept 16, 1977, the field of percutaneous coronary
intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary …